Skip to content

Effect of the multidisciplinary risk assessment and management program for iodinated contrast media

Effect of the multidisciplinary risk assessment and management program for iodinated contrast media

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071107
Enrollment
Unknown
Registered
2023-05-05
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unlimited

Interventions

experimental group:Risk management of iodine contrast infusion in a multidisciplinary collaborative model
Control group:Risk management of iodine contrast infusion in a conventional medical model

Sponsors

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University,
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients receiving enhanced CT examination with iodine contrast media in Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital 2) Patients who are willing to perform a multidisciplinary collaborative risk assessment prior to iodine contrast media injection

Exclusion criteria

Exclusion criteria: 1) Cases in which other surgical procedures were performed within 2 weeks 2) Re-hospitalization for other reasons within 2 weeks. 3) Patients whose follow-up data were missing after examination, and it was impossible to determine the end event 4) pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Incidence of adverse reactions of iodine contrast media;

Countries

China

Contacts

Public ContactHuiyan Jiang

Medical Ethics Committee of Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital

Jianghy1027@163.com+86 18260626845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026